Morgan Stanley’s Solventum SOLV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$118M Sell
1,533,215
-229,792
-13% -$16.8M 0.01% 1426
2026
Q1
$115M Buy
1,763,007
+102,101
+6% +$7.58M 0.01% 1322
2025
Q4
$132M Buy
1,660,906
+193,154
+13% +$14.8M 0.01% 1214
2025
Q3
$107M Buy
1,467,752
+139,657
+11% +$10.2M 0.01% 1352
2025
Q2
$101M Sell
1,328,095
-47,059
-3% -$3.33M 0.01% 1316
2025
Q1
$105M Buy
1,375,154
+14,505
+1% +$1.08M 0.01% 1224
2024
Q4
$89.9M Sell
1,360,649
-60,391
-4% -$4.23M 0.01% 1337
2024
Q3
$99.1M Sell
1,421,040
-154,749
-10% -$9.31M 0.01% 1245
2024
Q2
$83.3M Buy
1,575,789
+1,567,096
+18,027% +$95.1M 0.01% 1315
2024
Q1
$605K Buy
+8,693
New +$651K ﹤0.01% 5224

Other funds holding SOLV

Morgan Stanley's SOLV Position: Q2 2026 in Review

Morgan Stanley reduced its Solventum (SOLV) stake by 13% in Q2 2026, selling an estimated $16.8M and leaving 1,533,215 shares worth $118M. The position accounts for 0.01% of the portfolio, ranked #1426.

Morgan Stanley first reported a position in SOLV in Q1 2024 and has held it in 10 quarters since. The position peaked at $132M in Q4 2025. 881 funds tracked by Wall St. Rank hold SOLV as of Q2 2026.

  • Morgan Stanley held 1,533,215 shares of Solventum worth $118M as of Q2 2026.
  • Morgan Stanley sold 229,792 Solventum shares in Q2 2026, an estimated $16.8M.
  • Solventum made up 0.01% of Morgan Stanley's portfolio in Q2 2026, its #1426 holding.
  • Morgan Stanley first reported a position in Solventum in Q1 2024 and has held it in 10 quarters since.
  • Morgan Stanley's Solventum position peaked at $132M in Q4 2025.
  • 881 funds tracked by Wall St. Rank held Solventum as of Q2 2026.

Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.